Endliss Technology, Inc.
USPTO PatentsView assignee record - 6 granted patents across 0 technology areas, recorded in grant years 2021–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength.
The verdict
According to USPTO PatentsView, Endliss ranks #40,023 of 49,997 tracked US assignees by granted-patent volume, with 6 patents across 0 technology areas.
- #40,023
- of 49,997 US assignees by volume
- 23rd percentile
- by Innovation Score (27.3/100)
- 1.0
- avg claims per patent
USPTO PatentsView assignee plate
Corpus R40023 · US Corporation #40,023 · 6 grants
GRANTS-MICRO · LOWER-Q · PHOTO-FINISH · CPC-UNK · INNOV-THIN · CLAIMS-SPARSE · TYPE-USCORP · SPAN-YRS · BOOK-RICH
- GRANTS-MICRO 6 grants
- LOWER-Q #40,023/49,997
- PHOTO-FINISH En-Fab
- CPC-UNK CPC blank
- INNOV-THIN 27.3/100
- CLAIMS-SPARSE 1.0 claims/avg
- TYPE-USCORP US Corporation
- SPAN-YRS 2021–2024 · 4y
- BOOK-RICH 8/10 fields
Nearest grant-volume peer: En-Fab Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Endliss’s 27.3 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Endliss
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Endliss Technology · this assignee 27
Endliss Technology · this assignee
27 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Endliss's Innovation Score is 27.3/100 (23rd percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Endliss?
Each dot is one of Endliss’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Endliss’s own 1.0 claims/patent is at or below the 17.0 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.
Where Endliss's grants concentrate
Endliss Technology, Inc. is a focused PatentsView assignee: 0 CPC subclasses . Peak complete grant year is 2022 (3 grants) versus a trough of 1 in 2021. By volume, Endliss sits between En RX Chemical, Inc. and Energenesis Biomedical Co., Ltd..
Endliss's three-year grant acceleration
Endliss Technology, Inc. shows 5 grants in 2022–2024 against only 1 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at Endliss's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- En RX Chemical
En RX Chemical, Inc.
6 patents
- En-fab
En-Fab Inc.
6 patents
- Enclear Therapies
EnClear Therapies, Inc.
6 patents
- Encoded Therapeut…
Encoded Therapeutics, Inc.
6 patents
- Endo Operations
Endo Operations Limited
6 patents
- Endobar Solutions
Endobar Solutions LLC
6 patents
- Endur ID
Endur ID, Inc.
6 patents
- Energenesis Biome…
Energenesis Biomedical Co., Ltd.
6 patents
- Endliss Technology ◀
Endliss Technology, Inc.
6 patents
What this shows Endliss holds 6 patents at rank #40,074, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Endliss
By rank, the assignees closest to #40,074 in granted patent volume.
- En RX Chemical, Inc. #40,070 · 6 patents
- En-Fab Inc. #40,071 · 6 patents
- EnClear Therapies, Inc. #40,072 · 6 patents
- Encoded Therapeutics, Inc. #40,073 · 6 patents
- Endo Operations Limited #40,075 · 6 patents
- Endobar Solutions LLC #40,076 · 6 patents
- Endur ID, Inc. #40,077 · 6 patents
- Energenesis Biomedical Co., Ltd. #40,078 · 6 patents
Endliss's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
27 23rd percentile higher than 23% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2021–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2021 | 1 | 16.7% |
| 2022 | 3 | 50.0% |
| 2023 | 1 | 16.7% |
| 2024 | 1 | 16.7% |
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Endliss Technology, Inc.'s patent record in context - here's where to go next.
- Ranked #40,023 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Endliss Technology, Inc. against En RX Chemical, Inc., an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 27.3/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.